<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03398655</url>
  </required_header>
  <id_info>
    <org_study_id>VB-111-701/GOG-3018</org_study_id>
    <nct_id>NCT03398655</nct_id>
  </id_info>
  <brief_title>A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)</brief_title>
  <acronym>OVAL</acronym>
  <official_title>A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined With Paclitaxel vs. Paclitaxel Combined With Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vascular Biogenics Ltd. operating as VBL Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GOG Foundation, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vascular Biogenics Ltd. operating as VBL Therapeutics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this phase 3, randomized, multicenter study is to compare VB-111 and
      paclitaxel to placebo and paclitaxel in adult patients with Recurrent Platinum-Resistant
      Ovarian Cancer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 19, 2017</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>From 100 days following randomization until death from any cause (up to 5 years after last study treatment)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Progression Free Survival (PFS) by RECIST 1.1</measure>
    <time_frame>From randomization until progression defined according to RECIST 1.1 or death, whichever occurs first (up to 5 years after last study treatment)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Combined CA-125 and RECIST 1.1 response (GCIG)</measure>
    <time_frame>From date of study entry until the date of death from any cause, or up to 5 years after last study treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CA-125 Response (GCIG)</measure>
    <time_frame>From date of study entry until the date of death from any cause, or up to 5 years after last study treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objective response rate (ORR) by RECIST 1.1</measure>
    <time_frame>From date of study entry until the date of death from any cause, or up to 5 years after last study treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Recurrent Platinum Resistant Ovarian Cancer</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>VB-111 + Paclitaxel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Placebo + Paclitaxel</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>VB-111 + Paclitaxel</intervention_name>
    <description>VB-111 will be administered intravenously at a dose of 1x10e13 VPs every 2 months Paclitaxel will be administered intravenously at a dose of 80mg/m2 every week</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo + Paclitaxel</intervention_name>
    <description>Placebo will be administered intravenously every 2 months Paclitaxel will be administered intravenously at a dose of 80mg/m2 every week</description>
    <arm_group_label>Arm 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Female patients ≥18 years of age

          2. Histologically confirmed epithelial ovarian cancer and documented disease.

          3. Patients must have platinum-resistant disease

          4. Patients must have disease that is measurable according to RECIST 1.1 and require
             chemotherapy treatment.

          5. ECOG PS 0-1.

          6. Adequate hematological functions:

               -  ANC ≥ 1000/mm3

               -  PLT ≥ 100,000/mm3

               -  PT and PTT (seconds) &lt; 1.2 X ULN. Patients who are anticoagulated do not need to
                  meet criteria for PT and PTT.

          7. Patients who are known to carry a BRCA mutation may be enrolled only after (following
             PARP inhibitor treatment failure, or being intolerant of, or ineligible for PARP
             inhibitor treatment).

        Exclusion Criteria:

          1. Non-epithelial tumors (Carcino-sarcomas are excluded)

          2. Ovarian tumors with low malignant potential (i.e. borderline tumors) clear cell
             carcinomas, grade 1 serous tumors or mucinous tumors.

          3. History of other clinically active malignancy within 5 years of enrollment, except for
             tumors with a negligible risk for metastasis or death, such as adequately controlled
             basal-cell carcinoma, adequately controlled, non-metastatic squamous-cell carcinoma of
             the skin, or carcinoma in situ of the cervix or breast.

          4. Previous ovarian cancer treatment with &gt;5 anticancer regimens.

          5. Any prior radiotherapy to the pelvis or whole abdomen.

          6. Inadequate liver function, defined as serum creatinine &gt; ULN, unless calculated
             creatinine clearance &gt; 50ml/min (by Cockroft &amp; Gault formula):

               -  Serum (total) bilirubin &gt; ULN (Exception: documented Gilbert's disease patients
                  can be enrolled)

               -  Alkaline phosphatase, AST/SGOT or ALT/SGPT ≥2.5 x ULN (or ≥ 5 x ULN in the
                  presence of liver metastases).

          7. Inadequate renal function, defined as:

               -  Serum creatinine &gt; ULN OR

               -  Calculated creatinine clearance &lt; 50ml/min (by Cockroft &amp; Gault formula)

          8. New York Heart Association (NYHA) Grade II or greater congestive heart failure

          9. History of myocardial infarction or unstable angina within 6 months prior to day of
             randomization.

         10. History of stroke or transient ischemic attack within 6 months prior to day of
             randomization.

         11. Patient with proliferative and/or vascular retinopathy

         12. Known brain metastases

         13. History of hemoptysis or active GI bleeding within 6 month prior to day of
             randomization

         14. Evidence of bleeding diathesis or significant coagulopathy (in the absence of
             therapeutic anticoagulation).

         15. History of abdominal fistula or gastrointestinal perforation.

         16. Current signs and symptoms of bowel obstruction

         17. Uncontrolled active infection

         18. Patients who had evidence of disease progression during or up to 90 days from the last
             dose of the first line of platinum based therapy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Western Regional Medical Center</name>
      <address>
        <city>Goodyear</city>
        <state>Arizona</state>
        <zip>85338</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veta L. Clayton</last_name>
      <phone>623-207-3310</phone>
      <email>Veta.Clayton@ctca-hope.com</email>
    </contact>
    <investigator>
      <last_name>Natalie Godbee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arizona Oncology Associates, PC - HAL - USO</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Walsh</last_name>
      <phone>281-863-2586</phone>
      <email>karen.walsh@usoncology.com</email>
    </contact>
    <investigator>
      <last_name>Bradley Monk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Arizona Cancer Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85719</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yrma Burruel</last_name>
      <phone>520-694-9081</phone>
      <email>yburruel@uacc.arizona.edu</email>
    </contact>
    <investigator>
      <last_name>Setsuko Chambers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zeno Ashai</last_name>
      <phone>323-865-0463</phone>
      <email>Zeno.Ashai@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Koji Matsuo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UCLA-JCCC-Women's Health Clinical Research Unit</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonali S Namiranian</last_name>
      <phone>310-794-9095</phone>
      <email>snamiranian@mednet.ucla.edu</email>
    </contact>
    <investigator>
      <last_name>Joshua Cohen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Center for Cancer Prevention and Treatment at St. Joseph Hospital of Orange</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lavinia Dobrea</last_name>
      <phone>714-734-6220</phone>
      <email>Lavinia.Dobrea@stjoe.org</email>
    </contact>
    <investigator>
      <last_name>Tariq Mahmood, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, Irvine Medical Center/Chao Family Comprehensive Cancer Center</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Idelfonso</last_name>
      <phone>714-509-2261</phone>
      <email>midelfon@uci.edu</email>
    </contact>
    <investigator>
      <last_name>Krishnansu Tewari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California - San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katherine Bigay</last_name>
      <phone>415-885-7206</phone>
      <email>Katherine.Bigay@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Edwin Alvarez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sansum Clinic - USO</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <zip>93105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heidi Heitkamp</last_name>
      <phone>281-863-2586</phone>
      <email>hheitkam@ridleytreecc.org</email>
    </contact>
    <investigator>
      <last_name>Thomas Woliver, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Olive View UCLA Medical Center</name>
      <address>
        <city>Sylmar</city>
        <state>California</state>
        <zip>91342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bianca Alcantar</last_name>
      <phone>747-210-4529</phone>
      <email>bialcantar@dhs.lacounty.gov</email>
    </contact>
    <contact_backup>
      <last_name>Brooke Benavides</last_name>
      <phone>747-210-8812</phone>
      <email>bbenavides@dhs.lacounty.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Christine Holschneider, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hartford HealthCare Cancer Institute at the Hospital of Central Ct</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06053</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Putala</last_name>
      <phone>860-972-5018</phone>
      <email>sara.putala@hhchealth.org</email>
    </contact>
    <investigator>
      <last_name>Amy B rown, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hartford Healthcare</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Putala</last_name>
      <phone>860-972-5018</phone>
      <email>sara.putala@hhchealth.org</email>
    </contact>
    <investigator>
      <last_name>Amy B rown, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UF Health</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Lynn</last_name>
      <phone>352-265-0680</phone>
      <phone_ext>87658</phone_ext>
      <email>Melissa.Lynn@medicine.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Merry Markham, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Marrero</last_name>
      <phone>305-243-6248</phone>
      <email>axm2830@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Marilyn Huang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacey Worrell</last_name>
      <phone>404-778-5311</phone>
      <email>stacey.worrell@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Namita Khanna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lois Winkelman</last_name>
      <phone>312-942-2417</phone>
      <email>lois_a_winkelman@rush.edu</email>
    </contact>
    <investigator>
      <last_name>Summer Dewdney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carle Cancer Center</name>
      <address>
        <city>Urbana</city>
        <state>Illinois</state>
        <zip>61801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Sedberry</last_name>
      <phone>217-326-0281</phone>
      <email>michelle.sedberry@carle.com</email>
    </contact>
    <investigator>
      <last_name>Maria Grosse-Perdekamp, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Midwestern Regional Medical Center, Inc</name>
      <address>
        <city>Zion</city>
        <state>Illinois</state>
        <zip>60099</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cliona McAlister</last_name>
      <phone>847-731-1777</phone>
      <email>Cliona.mcalister@ctca-hope.com</email>
    </contact>
    <investigator>
      <last_name>Julian Schink, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Parkview Cancer Institute</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46845</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracy Thorne</last_name>
      <phone>260-266-7764</phone>
      <email>Tracy.Thorne@parkview.com</email>
    </contact>
    <investigator>
      <last_name>Iwona Podzielinski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University School of Medicine</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Alvey</last_name>
      <phone>317-278-6455</phone>
      <email>rlalvey@iu.edu</email>
    </contact>
    <investigator>
      <last_name>Jeanne Schilder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent Gynecologic Oncology</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia E Cruz</last_name>
      <phone>317-415-6747</phone>
      <email>cynthia.cruzrivera@ascension.org</email>
    </contact>
    <investigator>
      <last_name>Michael Callahan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kansas Cancer Center</name>
      <address>
        <city>Westwood</city>
        <state>Kansas</state>
        <zip>66205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jmaes Jeffery</last_name>
      <phone>913-945-8871</phone>
      <email>jjeffery2@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>Andrea Jewell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shar Ellixson</last_name>
      <phone>859-323-3975</phone>
      <email>swelli2@uky.edu</email>
    </contact>
    <investigator>
      <last_name>Frederick Ueland, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic Foundation</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Duffaut</last_name>
      <phone>504-842-2447</phone>
      <email>nicole.duffaut@ochsner.org</email>
    </contact>
    <investigator>
      <last_name>Katrina Wade, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Tait</last_name>
      <phone>410-328-3546</phone>
      <email>ntait@umm.edu</email>
    </contact>
    <contact_backup>
      <last_name>Janie Wangdali</last_name>
      <phone>410-328-3546</phone>
      <email>jwangdali@umm.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Dana M Roque, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Holy Cross Hospital</name>
      <address>
        <city>Silver Spring</city>
        <state>Maryland</state>
        <zip>20902</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lyudmila Kalnitskaya</last_name>
      <phone>301-754-7552</phone>
      <email>kalnitsl@holycrosshealth.org</email>
    </contact>
    <investigator>
      <last_name>James Barter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>20114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesse Sardell</last_name>
      <phone>617-643-4088</phone>
      <email>jsardell@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Richard Penson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>04801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caitlin McCarthy</last_name>
      <phone>734-615-5118</phone>
      <email>caitlimc@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Jean Siedel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karmanos Cancer Institute</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jasmine Hunt</last_name>
      <phone>313-576-9382</phone>
      <email>huntj@karmanos.org</email>
    </contact>
    <investigator>
      <last_name>Shelly Morris, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marbybeth McCarthy</last_name>
      <phone>313-916-7827</phone>
      <email>mmccart2@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Rabbie Hanna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dartmouth- Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline M. Kihwele</last_name>
      <phone>603-653-9056</phone>
      <email>Jacqueline.M.Kihwele@hitchcock.org</email>
    </contact>
    <investigator>
      <last_name>Evelyn Fleming, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Atlantic Health System/Morristown Medical Center</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07928</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Ginder</last_name>
      <phone>973-971-6608</phone>
      <email>nancy.ginder@atlantichealth.org</email>
    </contact>
    <investigator>
      <last_name>Nana Tchabo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rutgers New Jersey Medical School</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Randall Teeter</last_name>
      <phone>973-972-8367</phone>
      <email>randall.teeter@njms.rutgers.edu</email>
    </contact>
    <investigator>
      <last_name>Mark H Einstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New Mexico Cancer Care Alliance</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheri Westgate</last_name>
      <phone>505-925-0383</phone>
      <email>swestgate@salud.unm.edu</email>
    </contact>
    <investigator>
      <last_name>Carolyn Muller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Women's Cancer Care Associates, LLC</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Fredericks</last_name>
      <phone>518-458-1390</phone>
      <email>kfredericks@womenscancercareassociates.com</email>
    </contact>
    <investigator>
      <last_name>Joyce Barlin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwell Health Cancer Institute</name>
      <address>
        <city>Lake Success</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Templeton</last_name>
      <phone>516-734-8979</phone>
      <email>Mtempleton@northwell.edu</email>
    </contact>
    <investigator>
      <last_name>Veena John, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Laura and Isaac Perlmutter Cancer Center at NYU Langone</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Keith</last_name>
      <phone>929-455-2422</phone>
      <email>nancy.keith@nyulangone.edu</email>
    </contact>
    <investigator>
      <last_name>Douglas Levine, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Health Quest Medical Practice, Division of Gynecology/Oncology Gyno Dyson Cancer Center Vassar Brothers Medical Center</name>
      <address>
        <city>Poughkeepsie</city>
        <state>New York</state>
        <zip>12601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raminder Chadha</last_name>
      <phone>845-483-6456</phone>
      <email>rchadha@Health-quest.org</email>
    </contact>
    <investigator>
      <last_name>Heidi Godoy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanessa Gatmaitan</last_name>
      <phone>315-464-5788</phone>
      <email>GatmaitV@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Mary Cunningham, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UNC Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27707</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Gruhn</last_name>
      <phone>919-445-4212</phone>
      <email>jennifer_gruhn@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Linda Van Le, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University-Duke Cancer Institute</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kara Hagler</last_name>
      <phone>919-684-3780</phone>
      <email>kara.hagler@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Angeles Secord, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Miller</last_name>
      <phone>336-713-6770</phone>
      <email>cytmill@wakehealth.edu</email>
    </contact>
    <investigator>
      <last_name>Samuel Lentz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sanford Medical Center</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ellen Dierking</last_name>
      <phone>701-234-5688</phone>
      <email>ellen.dierking@sanfordhealth.org</email>
    </contact>
    <investigator>
      <last_name>Maria Bell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Hagood</last_name>
      <phone>513-584-5044</phone>
      <email>Val.Hagood@ucmail.uc.edu</email>
    </contact>
    <investigator>
      <last_name>Thomas Herzog, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Womens Cancer Center/Kettering Cancer Care</name>
      <address>
        <city>Kettering</city>
        <state>Ohio</state>
        <zip>45429</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wanda Caplinger</last_name>
      <phone>937-281-3900</phone>
      <email>wanda.caplinger@ketteringhealth.org</email>
    </contact>
    <investigator>
      <last_name>Thomas Reid, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center-Stephenson Cancer Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hee Sun Kim-Suh</last_name>
      <phone>405-271-8777</phone>
      <email>HeeSun-Kim@ouhsc.edu</email>
    </contact>
    <investigator>
      <last_name>Laura Holman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Luke's University Health Network</name>
      <address>
        <city>Bethlehem</city>
        <state>Pennsylvania</state>
        <zip>18015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diane Villasenor</last_name>
      <phone>484-526-7409</phone>
      <email>diane.villasenor@sluhn.org</email>
    </contact>
    <investigator>
      <last_name>Nicholas Taylor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Crossette</last_name>
      <phone>215-614-0234</phone>
      <email>Linda.Crossette@pennmedicine.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Ashley Haggerty, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fox Chase Cancer Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brittney Cirone</last_name>
      <phone>215-728-1133</phone>
      <email>Brittney.Cirone@fccc.edu</email>
    </contact>
    <investigator>
      <last_name>Christina Chu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West Penn Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Siobhan Guyach</last_name>
      <phone>412-578-4517</phone>
      <email>siobhan.guyach@ahn.org</email>
    </contact>
    <investigator>
      <last_name>Thomas Krivak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>GHS Cancer Institute</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gina Norris</last_name>
      <phone>864-242-2762</phone>
      <email>gnorris@ghs.org</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Elder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sanford Clinical Research</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Johnson</last_name>
      <phone>605-312-3343</phone>
      <email>ashley.johnson9@sanfordhealth.org</email>
    </contact>
    <investigator>
      <last_name>Maria Bell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Dumont</last_name>
      <phone>615-936-5173</phone>
      <email>anna.dumont@vumc.org</email>
    </contact>
    <investigator>
      <last_name>Marta Crispens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Oncology, Austin Central - USO</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78731</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaelyn Kappeler</last_name>
      <phone>512-427-9400</phone>
      <email>Kaelyn.kappeler@usoncology.com</email>
    </contact>
    <investigator>
      <last_name>Michael G Teneriello, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonia Robazetti</last_name>
      <phone>832-217-5571</phone>
      <email>sonia.c.robazetti@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Joseph Lucci, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universtiy of Vermont</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Wilson</last_name>
      <phone>802-565-4101</phone>
      <email>Karen.m.wilson@uvm.edu</email>
    </contact>
    <investigator>
      <last_name>Cheung Wong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire Kostechka</last_name>
      <phone>608-263-2079</phone>
      <email>kostechka@wisc.edu</email>
    </contact>
    <investigator>
      <last_name>Lisa Barroilhet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Froedtert and Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carli Jarman</last_name>
      <phone>414-805-6647</phone>
      <email>cjarman@mcw.edu</email>
    </contact>
    <investigator>
      <last_name>William Bradley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rambam Medical Center</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tali Lifshits-Gritzman</last_name>
      <phone>972-4-7771796</phone>
      <email>gyn_onco@rambam.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Amnon Amit, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hadassah Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noa Kamin</last_name>
      <phone>+972-2-6776709</phone>
      <email>noakamin@hadassah.org.il</email>
    </contact>
    <investigator>
      <last_name>David Edelmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shaare Tzedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dalia Sherizen</last_name>
      <phone>972-2-6555424</phone>
      <email>daliash@szmc.org.il</email>
    </contact>
    <investigator>
      <last_name>Ora Rosengarten, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rabin Medical Center</name>
      <address>
        <city>Petach Tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eyal Peretz</last_name>
      <phone>972-3-9377428</phone>
      <email>EyalPe@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Daliah Tsoref, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chaim Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yona Gilady</last_name>
      <phone>03-5309091</phone>
      <email>yona.gilady@sheba.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Ronnie Shapira-Frommer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaplan Medical Center, Department of Oncology</name>
      <address>
        <city>Rehovot</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elinor Dahari</last_name>
      <phone>972-8-9441007</phone>
      <email>elinorda@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Adelya Yachnin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.vblrx.com/</url>
    <description>VBL Therapeutics Company Website</description>
  </link>
  <link>
    <url>https://ovaltrial.com/</url>
    <description>OVAL study Website</description>
  </link>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 7, 2018</study_first_submitted>
  <study_first_submitted_qc>January 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 12, 2018</study_first_posted>
  <last_update_submitted>June 29, 2020</last_update_submitted>
  <last_update_submitted_qc>June 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Recurrent Ovarian cancer</keyword>
  <keyword>Platinum resistant ovarian cancer</keyword>
  <keyword>Ovarian cancer</keyword>
  <keyword>Ovarian carcinoma</keyword>
  <keyword>Epithelial ovarian cancer</keyword>
  <keyword>paclitaxel</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Ovarian Epithelial</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
    <mesh_term>Albumin-Bound Paclitaxel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

